As always, it is crucial to consult with a qualified healthcare professional who can provide personalized recommendations based on individual health needs and goals
Changes in lean body mass with glucagon-like peptide-1- based therapies and mitigation strategies
Digestive Support for GLP-1 Treatments: GLP-1 agonists frequently cause digestive side effects, with nausea occurring in 40% of cases, vomiting in 25%, and bowel disturbances in 23%, often leading to treatment discontinuation (Sun F et al., Diabetes Technology & Therapeutics , 2015)
Clinical trials show that people can lose 15-22.5% of their total body weight within 72 weeks
MK 677 also affects other metabolic processes in research models, lipid metabolism and overall composition changes through growth hormone release
Muscle separation or rectus diastasis causes midline or generalised bulging